Fifth Global Congress on Prostate Cancer - 2017

31 Jul 2017

Professor Stricker presented his results of the NanoKnife and also of his robotic radical prostatectomy experience to a large audience at the PROSCA 2017 Conference in Lisbon Portugal.

The most important areas to monitor in one's own practice and for that matter in all practices are the following:

The NanoKnife treatment, which is a focal ablation of the prostate, shows that with experience and with care there is a 97% clearance in the area of treatment with remarkable preservation of continence and potency. The intermediate term results with a minimum of a year follow-up were presented in the largest experience in the world at this stage. Attached is a copy of the poster.

In addition, he presented the results of the learning curve of the robotic radical prostatectomy over a very long period of time.

To view PDF versions of the 2 presentation posters click the links below:

nerve_sparing_moore.pdfFocal irreversible electroporation as primary and salvage treatment for prostate cancer

nerve_sparing_moore.pdfSuperior biochemical recurrence and quality of life outcomes are achievable with robotic radical prostatectomy versus open ...

About Phillip

Phillip is the Chairman of the Department of Urology, St Vincent's Private Hospital and Clinic since 2003, and a Director of the St Vincent's Prostate Cancer Centre.

The Australian Prostate Cancer Research Centre in New South Wales recently appointed him as clinical director. He is also a member of the National Prostate Cancer Research Centre

Philip is currently the highest volume robotic surgeon in Australasia

He is perhaps best known for his work developing nerve sparing techniques to help patients maximise potency